Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology

With the rapid growth of molecular biology, in vivo imaging of such molecular process (i.e., molecular imaging) has been well developed. The molecular imaging has been focused on justifying advanced treatments and for assessing the treatment effects. Most of molecular imaging has been developed using PET camera and suitable PET radiopharmaceuticals. However, this technique cannot be widely available and we need alternative approach. 123I-labeled compounds have been also suitable for molecular imaging using single-photon computed tomography (SPECT) 123I-labeled meta-iodobenzylguanidine (MIBG) has been used for assessing severity of heart failure and prognosis. In addition, it has a potential role to predict fatal arrhythmia, particularly for those who had and are planned to receive implantable cardioverter-defibrillator treatment. 123I-beta-methyl-iodophenylpentadecanoic acid (BMIPP) plays an important role for identifying ischemia at rest, based on the unique capability to represent persistent metabolic alteration after recovery of ischemia, so called ischemic memory. Since BMIPP abnormalities may represent severe ischemia or jeopardized myocardium, it may permit risk analysis in CAD patients, particularly for those with chronic kidney disease and/or hemodialysis patients. This review will discuss about recent development of these important iodinated compounds.

• Publication year

  2010

• Venue

  Journal of Nuclear Cardiology

• Publication date

  2010-11-17

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1007/s12350-010-9305-4PMID 21082300PMCID 3032201
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• UK Renal Registry 15th Annual Report: Chapter 5 Survival and Causes of Death of UK Adult Patients on Renal Replacement Therapy in 2011: National and Centre-Specific Analyses

  2013cited by this paper
• Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial.

  2010cited by this paper
• Metaiodobenzylguanidine imaging comes of age. A new arrow in the prognostic quiver for heart failure patients.

  2010cited by this paper
• UK Renal Registry 12th Annual Report (December 2009): chapter 7: survival and causes of death of UK adult patients on renal replacement therapy in 2008: national and centre-specific analyses.

  2010cited by this paper
• Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia : quantification of cardiac tracers in patients with ICDs

  2010cited by this paper
• Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.

  2010cited by this paper
• Impaired Cardiac Sympathetic Innervation and Myocardial Perfusion Are Related to Lethal Arrhythmia: Quantification of Cardiac Tracers in Patients with ICDs

  2010cited by this paper
• Prognostic value of myocardial metabolic imaging with BMIPP in the spectrum of coronary artery disease: A systematic review

  2010influential reference
• Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

  2010cited by this paper
• Guidelines for device-based therapy of cardiac rhythm abnormalities.

  2009cited by this paper
• UK Renal Registry 11th Annual Report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on Renal Replacement Therapy in 2007: national and centre-specific analyses

  2009cited by this paper
• Characterization of Japanese standards for myocardial sympathetic and metabolic imaging in comparison with perfusion imaging

  2009cited by this paper
• Myocardial β-Adrenergic Receptor Density Assessed by 11C-CGP12177 PET Predicts Improvement of Cardiac Function After Carvedilol Treatment in Patients with Idiopathic Dilated Cardiomyopathy

  2009cited by this paper
• Guidelines for device-based therapy of cardiac rhythm abnormalities.

  2009cited by this paper
• Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v

  2009cited by this paper
• UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analyses

  2009cited by this paper
• Cardiac positron emission tomography.

  2009cited by this paper
• Indications for implantable cardioverter-defibrillators based on evidence and judgment.

  2009cited by this paper
• 123I-mIBG Scintigraphy to Predict Inducibility of Ventricular Arrhythmias on Cardiac Electrophysiology Testing: A Prospective Multicenter Pilot Study

  2008cited by this paper
• Multimodality cardiovascular molecular imaging, part I.

  2008cited by this paper
• Diagnostic accuracy of β-methyl-p-[123I]-iodophenyl-pentadecanoic acid (BMIPP) imaging: A meta-analysis

  2008cited by this paper
• Predicting the Need for an Implantable Cardioverter Defibrillator Using Cardiac Metaiodobenzylguanidine Activity Together with Plasma Natriuretic Peptide Concentration or Left Ventricular Function

  2008influential reference
• ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker

  2008cited by this paper
• Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging.

  2008cited by this paper
• A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

  2008cited by this paper
• Myocardial fatty acid imaging identifies a group of hemodialysis patients at high risk for cardiac death after coronary revascularization.

  2008cited by this paper
• Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.

  2008cited by this paper
• ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.

  2008cited by this paper
• I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study

  2008cited by this paper
• Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome.

  2008cited by this paper
• ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker

  2008cited by this paper
• Prognostic Study of Cardiac Events in Japanese High Risk Hemodialysis Patients Using 123I‐BMIPP‐SPECT: B‐SAFE Study Design

  2008cited by this paper
• The Japanese experience with metabolic imaging in the clinical setting

  2007influential reference
• Decreased Myocardial β-Adrenergic Receptor Density in Relation to Increased Sympathetic Tone in Patients with Nonischemic Cardiomyopathy

  2007cited by this paper
• Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation

  2007cited by this paper
• Cardiovascular molecular imaging.

  2007cited by this paper
• Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

  2005cited by this paper
• Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease

  2005cited by this paper
• Metabolic Imaging With &bgr;-Methyl-p-[123I]-Iodophenyl-Pentadecanoic Acid Identifies Ischemic Memory After Demand Ischemia

  2005cited by this paper
• Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure.

  2005cited by this paper
• Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients.

  2004cited by this paper
• Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: comparison with stress thallium imaging

  2004cited by this paper
• Usefulness of123I-metaiodobenzylguanidine myocardial scintigraphy in the prediction of cardiac events in patients with cardiomyopathy showing stabilization of symptoms or preserved cardiac function

  2004cited by this paper
• Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.

  2004cited by this paper
• Diagnostic value of 123I-betamethyl-p-iodophenyl-pentadecanoic acid (BMIPP) single photon emission computed tomography (SPECT) in patients with chest pain. Comparison with rest-stress 99mTc-tetrofosmin SPECT and coronary angiography.

  2004cited by this paper
• Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine‐stimulated coronary flow response in human subjects

  2004cited by this paper
• Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator

  2004cited by this paper
• Implantable Defibrillators and Sudden Cardiac Death

  2004cited by this paper
• Incremental predictive value of myocardial scintigraphy with 123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention

  2004cited by this paper
• Diagnostic Value of 123 I-Betamethyl-p-Iodophenyl-Pentadecanoic Acid ( BMIPP ) Single Photon Emission Computed Tomography ( SPECT ) in Patients With Chest Pain Comparison With Rest-Stress 99 mTc-Tetrofosmin SPECT and Coronary Angiography

  2004cited by this paper
• Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.

  2003cited by this paper
• I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator

  2003influential reference
• Pathophysiological implications of insulin resistance on vascular endothelial function

  2003cited by this paper
• Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction.

  2003cited by this paper
• Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake

  2003cited by this paper
• Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.

  2002cited by this paper
• Prognostic values of perfusion-metabolic mismatch in Tl-201 and BMIPP scintigraphic imaging in patients with chronic coronary artery disease and left ventricular dysfunction undergoing revascularization

  2002cited by this paper
• Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months.

  2002cited by this paper
• Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain.

  2001cited by this paper
• Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy.

  2001cited by this paper
• Resting 123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain.

  2000cited by this paper
• Epidemiology of cardiovascular disease in chronic renal disease

  2000cited by this paper
• The role of fatty acids in cardiac imaging.

  2000influential reference
• Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance.

  2000cited by this paper
• Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction

  2000cited by this paper
• Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart.

  1999cited by this paper
• Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy.

  1999cited by this paper
• Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.

  1999cited by this paper
• Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of β blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment

  1999cited by this paper
• Microvascular function relates to insulin sensitivity and blood pressure in normal subjects.

  1999cited by this paper
• Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

  1999cited by this paper
• Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts

  1998cited by this paper
• Epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper
• Use of 123I-BMIPP single-photon emission tomography to estimate areas at risk following successful revascularization in patients with acute myocardial infarction

  1998cited by this paper
• Comparison of resting beta-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina.

  1997cited by this paper
• Iodine-123-BMIPP imaging in unstable angina: a guide for interventional strategy.

  1997cited by this paper
• Relationship of insulin resistance to microvascular dysfunction in subjects with fasting hyperglycaemia

  1997cited by this paper
• Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease.

  1997cited by this paper
• Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.

  1997cited by this paper
• Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

  1997cited by this paper
• Comparison of Resting β-Methyl-Iodophenyl Pentadecanoic Acid (BMIPP) and Thallium-201 Tomography Using Quantitative Polar Maps in Patients With Unstable Angina

  1997cited by this paper
• Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.

  1996cited by this paper
• Cardiac Positron Emission Tomography

  1996cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction

  1996cited by this paper
• Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction.

  1996cited by this paper
• Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT

  1995influential reference
• Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina.

  1995cited by this paper
• Uptake mechanisms of meta-[123I]iodobenzylguanidine in isolated rat heart.

  1995cited by this paper
• N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

  1994cited by this paper
• Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease.

  1993cited by this paper
• Positron emission tomography with 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy.

  1993cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.

  1992cited by this paper
• Myocardial β-Adrenergic Desensitization and Neuronal Norepinephrine Uptake Function in Idiopathic Dilated Cardiomyopathy

  1992cited by this paper
• Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.

  1992cited by this paper
• Sympathetic stimulation and arrhythmias.

  1991cited by this paper
• Role of the sympathetic nervous system in the genesis of ventricular arrhythmia.

  1990cited by this paper
• Ischemic Heart Disease in Chronic Renal Failure: Management Considerations

  1989cited by this paper
• Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants.

  1989cited by this paper

• Long-term survival and durable recovery of heart failure in patients with triglyceride deposit cardiomyovasculopathy treated with tricaprin

  2025cites this paper
• Cardiovascular imaging in cardio-oncology

  2024cites this paper
• Current status and perspectives of nuclear cardiology

  2023cites this paper
• Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging.

  2023cites this paper
• Practice Recommendation for Measuring Washout Rates in 123I-BMIPP Fatty Acid Images

  2023cites this paper
• Practice recommendation for measuring washout rates in 123I-BMIPP fatty acid images

  2023cites this paper
• Synthesis and Preliminary Evaluation of an ^18F-labeled Oleate Analog to Image Fatty Acid Beta-Oxidation in the Absence of Metabolic Defluorination

  2022cites this paper
• Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.

  2022cites this paper
• 123I-BMIPP Scintigraphy Shows That CNT-01 (Tricaprin) Improves Myocardial Lipolysis in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy: First Randomized Controlled, Exploratory Trial for TGCV.

  2022cites this paper
• Prediction of Serious Adverse Events of Patients with Hypertrophic Cardiomyopathy by Magnetic Resonance.

  2021cites this paper
• Effects of feeding condition on the myocardial and hepatic accumulation of radioiodine-labeled BMIPP in mice

  2020cites this paper
• Status of Nuclear Cardiology Progress in Japan 2020

  2020cites this paper
• Imaging Metabolically Active Fat: A Literature Review and Mechanistic Insights

  2019cites this paper
• JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure　- Digest Version.

  2019cites this paper
• Present Status of Medical Radiation and Nuclear Cardiology Usage in Japan: A Discussion at the American Society of Nuclear Cardiology Joint Symposium

  2018influential citation
• Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure

  2017cites this paper
• Energy Failure Hypothesis for Takotsubo Cardiomyopathy

  2017cites this paper
• Design of Radioprobes for Pet and Spect Imaging

  2016cites this paper
• Tracing ischemic memory by metabolic pathways: BMIPP and beyond

  2016cites this paper
• Radiolabeled BMIPP for imaging hepatic fatty acid metabolism: evaluation of hepatic distribution and metabolism in mice at various metabolic statuses induced by fasting in comparison with palmitic acid.

  2015cites this paper
• Tracer Application in Cardiovascular Imaging: A Triple Jump

  2015cites this paper
• Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence

  2015cites this paper
• Molecular imaging of brown adipose tissue in health and disease

  2014cites this paper
• Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations

  2014cites this paper
• Cochlear implants

  2014influential citation
• Novel Radiopharmaceuticals in Cardiovascular Medicine: Present and Future.

  2014cites this paper
• Research Article Novel Radiopharmaceuticals in Cardiovascular Medicine: Present and Future

  2014cites this paper
• Prone-position acquisition of myocardial 123 I-metaiodobenzylguanidine (MIBG) SPECT reveals regional

  2014cites this paper
• Prone-position acquisition of myocardial 123I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using 11C-hydroxyephedrine PET/CT

  2014cites this paper
• Cardiovascular molecular imaging: new methodological strategies.

  2013cites this paper
• Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure.

  2013influential citation
• Advances in cardiac SPECT and PET imaging: overcoming the challenges to reduce radiation exposure and improve accuracy.

  2013cites this paper
• The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure

  2013cites this paper
• Imaging strategies for acute chest pain in the emergency department.

  2013cites this paper
• imaging techniques and coronary artery disease - a review

  2013cites this paper
• Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure.

  2013cites this paper
• FACULDADE DE MEDICINA DA UNIVERSIDADE DE COIMBRA TRABALHO FINAL DO 6o ANO MÉDICO COM VISTA À ATRIBUIÇÃO DO GRAU DE MESTRE NO ÂMBITO DO CICLO DE ESTUDOS DE MESTRADO INTEGRADO EM MEDICINA

  2012cites this paper
• Guidelines for clinical use of cardiac nuclear medicine (JCS 2010) – digest version – .

  2012cites this paper
• Age-related maximum heart rate among ischemic and nonischemic heart failure patients receiving β-blockade therapy.

  2012cites this paper
• LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment

  2012cites this paper
• 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass

  2012cites this paper
• Myocardial perfusion scintigraphy: past, present and future.

  2011cites this paper
• Newer Applications of Nuclear Cardiology in Systolic Heart Failure: Detecting Coronary Artery Disease and Guiding Device Therapy

  2011cites this paper
• Survey of the Performance of Commercial Dose Calibrators for Measurement of 123I Activity

  2011cites this paper
• Validation of automated quantitation of myocardial perfusion and fatty acid metabolism abnormalities on SPECT images.

  2011cites this paper
• Cochlear implant

  2010influential citation